SCHEMBL30660985

SCHEMBL30660985

CC(C)(C)OC(=O)N1CC(=O)Nc2cc(Br)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 1/20 0.46
CDK1 P06493 1/20 0.46
CCNB1 P14635 1/20 0.46
GSK3B P49841 1/20 0.46
CCNB3 Q8WWL7 1/20 0.46
MAPK1 P28482 2/20 0.46
GAA P10253 2/20 0.44
LMNA P02545 2/20 0.44
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 1/20 0.41
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41
TUBA4A P68366 1/20 0.41
TUBB4B P68371 1/20 0.41
TUBB3 Q13509 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22278392 1.00 CCNB2 (0.46) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL28585711 0.84 CDK1 (0.38) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL31539452 0.83 MAPK1 (0.49) MAPK1GAALMNAKMT2AMEN1
SCHEMBL7997935 0.82 SMN1; SMN2 (0.61) MAPK1GAALMNANPC1RAB9A
SCHEMBL30660973 0.79 MAPK1 (0.46) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL22278558 0.79 MAPK1 (0.46) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL30660980 0.79 MAPK1 (0.46) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL1253195 0.78 CCNB2 (0.38) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL22278711 0.78 MAPK1 (0.54) MAPK1GAALMNARAB9AKMT2A
SCHEMBL23152289 0.78 ALDH1A1 (0.46) MAPK1GAALMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112839931-B 1,2,3, 4-tetrahydroquinoxaline derivative, and preparation method and application thereof 上海和誉生物医药科技有限公司 2023-12-01 CN disclosed